Louisiana State Employees Retirement System Arrowhead Pharmaceuticals, Inc. Transaction History

Louisiana State Employees Retirement System

$5.33 Billion
Q3 2024

A detailed history of Louisiana State Employees Retirement System transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 34,500 shares of ARWR stock, worth $654,120. This represents 0.01% of its overall portfolio holdings.

Number of Shares

34,500

Previous 35,100 1.71%

Holding current value

$654,120

Previous $912,000 26.86%

% of portfolio

0.01%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$19.36 - $29.54 $11,616 - $17,724	-600 Reduced 1.71%	34,500 $667,000
Q2 2024 Jul 24, 2024	SELL	$21.87 - $28.24 $13,122 - $16,944	-600 Reduced 1.68%	35,100 $912,000
Q1 2024 Apr 23, 2024	BUY	$27.21 - $39.48 $152,376 - $221,087	5,600 Added 18.6%	35,700 $1.02 Million
Q4 2023 Jan 29, 2024	SELL	$21.2 - $31.03 $6,360 - $9,309	-300 Reduced 0.99%	30,100 $921,000
Q3 2023 Oct 17, 2023	SELL	$26.2 - $36.08 $20,960 - $28,864	-800 Reduced 2.56%	30,400 $816,000
Q2 2023 Jul 18, 2023	BUY	$25.16 - $41.38 $62,900 - $103,450	2,500 Added 8.71%	31,200 $1.11 Million
Q1 2023 Apr 19, 2023	BUY	$23.68 - $38.51 $9,472 - $15,404	400 Added 1.41%	28,700 $728,000
Q4 2022 Jan 24, 2023	BUY	$28.0 - $40.56 $2,800 - $4,056	100 Added 0.35%	28,300 $1.15 Million
Q3 2022 Oct 19, 2022	BUY	$29.63 - $48.31 $11,852 - $19,324	400 Added 1.44%	28,200 $932,000
Q2 2022 Jul 20, 2022	BUY	$27.79 - $50.61 $5,558 - $10,122	200 Added 0.72%	27,800 $1.19 Million
Q1 2022 Apr 22, 2022	BUY	$39.62 - $69.97 $31,695 - $55,976	800 Added 2.99%	27,600 $1.26 Million
Q4 2021 Jan 14, 2022	BUY	$58.09 - $82.51 $11,618 - $16,502	200 Added 0.75%	26,800 $1.78 Million
Q3 2021 Oct 12, 2021	SELL	$58.38 - $84.96 $23,352 - $33,984	-400 Reduced 1.48%	26,600 $1.66 Million
Q1 2021 Apr 14, 2021	BUY	$61.35 - $90.47 $79,755 - $117,611	1,300 Added 5.06%	27,000 $1.79 Million
Q4 2020 Jan 11, 2021	BUY	$43.82 - $85.37 $8,764 - $17,074	200 Added 0.78%	25,700 $1.97 Million
Q3 2020 Oct 19, 2020	BUY	$33.21 - $51.27 $3,321 - $5,127	100 Added 0.39%	25,500 $1.1 Million
Q2 2020 Jul 13, 2020	BUY	$26.12 - $43.27 $31,344 - $51,924	1,200 Added 4.96%	25,400 $1.1 Million
Q4 2019 Jan 17, 2020	SELL	$28.14 - $73.01 $309,540 - $803,110	-11,000 Reduced 31.25%	24,200 $1.54 Million
Q3 2019 Oct 24, 2019	SELL	$26.26 - $34.86 $2,626 - $3,486	-100 Reduced 0.28%	35,200 $992,000
Q2 2019 Jul 15, 2019	BUY	$17.43 - $28.82 $615,279 - $1.02 Million	35,300 New	35,300 $958,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account

Louisiana State Employees Retirement System Arrowhead Pharmaceuticals, Inc. Transaction History